Apyx Medical (APYX) Operating Income Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.11% |
| Dec 31, 2025 | 32.19% |
| Sep 30, 2025 | 28.24% |
| Jun 30, 2025 | 16.03% |
| Mar 31, 2025 | 16.45% |
| Dec 31, 2024 | 12.55% |
| Sep 30, 2024 | 5.23% |
| Jun 30, 2024 | -4.64% |
| Mar 31, 2024 | -2.91% |
| Dec 31, 2023 | 0.20% |
| Sep 30, 2023 | -10.71% |
| Jun 30, 2023 | 15.89% |
| Mar 31, 2023 | -15.58% |
| Dec 31, 2022 | -12.88% |
| Sep 30, 2022 | -15.34% |
| Jun 30, 2022 | -35.55% |
| Mar 31, 2022 | -27.58% |
| Dec 31, 2021 | 27.83% |
| Sep 30, 2021 | -74.53% |
| Jun 30, 2021 | -51.30% |
| Mar 31, 2021 | -18.94% |
| Dec 31, 2020 | -8.73% |
| Sep 30, 2020 | -19.24% |
| Jun 30, 2020 | -31.84% |
| Mar 31, 2020 | -26.95% |
| Dec 31, 2019 | -27.16% |
| Sep 30, 2019 | -14.98% |
| Jun 30, 2019 | -20.42% |
| Mar 31, 2019 | -151.59% |
| Dec 31, 2018 | -46.12% |
| Sep 30, 2018 | -42.47% |
| Jun 30, 2018 | -27.09% |
| Mar 31, 2018 | -32.54% |
| Dec 31, 2017 | -93.73% |
| Sep 30, 2017 | -64.50% |
| Jun 30, 2017 | -49.39% |
| Mar 31, 2017 | -44.89% |
| Dec 31, 2016 | -43.90% |
| Sep 30, 2016 | -24.47% |
| Jun 30, 2016 | -23.98% |
| Mar 31, 2016 | -40.15% |